Researchers are evaluating predictive models to identify patients who are most likely to benefit from antidepressants.

What it means

This is a news article from Science (AAAS) reporting on multiple ongoing studies that are developing predictive models—using genetic data, brain scans, and AI analysis of health records—to identify which patients are most likely to respond to antidepressants. The goal is to move beyond trial-and-error prescribing and toward precision medicine for depression, though the tools are still experimental and face validation challenges.

Accuracy & sourcesGrounded

The claim is drawn from a reputable secondary source (Science News) that synthesizes several primary studies, including one in Nature and another in JMIR. The reporting is close to the underlying research, though it aggregates findings rather than reporting a single result, so specific performance metrics are not given. The provenance tier ('reports a named primary source') is appropriate, as the article cites named studies.

How new

The article was published on October 14, 2026, making this genuinely new coverage of current research.

Go deeper